Von Lubitz D K, Paul I A, Bartus R T, Jacobson K A
Laboratory of Bioorganic Chemistry, NIDDK, NIH, Bethesda, MD 20892.
Eur J Pharmacol. 1993 Nov 16;249(3):271-80. doi: 10.1016/0014-2999(93)90522-j.
Spatial memory acquisition in Morris water maze was tested in C57BL/6 mice. Animals were injected once daily with different doses of either N6-cyclopentyladenosine (CPA) or 8-cyclopentyl-1,3-dipropylxanthine (CPX). Drugs were administered for 9 days either concurrently with water maze testing (drugs injected 1 h after each trial), or prior to the entire block of trials. In the latter case, 1 day without injections preceded water maze experiments. Chronic administration of CPA resulted in a significant, dose-dependent reduction of target latencies, rapid development of spatial preference, and the absence of animals unable to perform the task. CPX treated animals did not show significant performance changes, and failed to develop spatial preference. Locomotor disturbances were not the cause of the observed effects. Our results indicate that chronic treatment with agents acting at adenosine A1 receptors results in behavioral effects that are significantly different from those observed following their acute administration. Therefore, particular caution is required in development of adenosine-based strategies targeted at neurodegenerative or cognitive disorders in which chronic treatment is advocated.
在C57BL/6小鼠中测试了在莫里斯水迷宫中的空间记忆获取。动物每天注射一次不同剂量的N6-环戊基腺苷(CPA)或8-环戊基-1,3-二丙基黄嘌呤(CPX)。药物给药9天,要么与水迷宫测试同时进行(每次试验后1小时注射药物),要么在整个试验组之前进行。在后一种情况下,在水迷宫实验前有1天不注射。长期给予CPA导致目标潜伏期显著且剂量依赖性降低,空间偏好迅速发展,并且没有动物无法完成任务。CPX处理的动物没有表现出显著的行为变化,也没有形成空间偏好。运动障碍不是观察到的效应的原因。我们的结果表明,长期用作用于腺苷A1受体的药物治疗会导致行为效应,这与急性给药后观察到的效应显著不同。因此,在开发针对神经退行性或认知障碍的基于腺苷的策略时需要特别谨慎,因为这些疾病主张进行长期治疗。